BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 20886866)

  • 1. Design of high-activity mutants of human butyrylcholinesterase against (-)-cocaine: structural and energetic factors affecting the catalytic efficiency.
    Zheng F; Yang W; Xue L; Hou S; Liu J; Zhan CG
    Biochemistry; 2010 Oct; 49(42):9113-9. PubMed ID: 20886866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational redesign of human butyrylcholinesterase for anticocaine medication.
    Pan Y; Gao D; Yang W; Cho H; Yang G; Tai HH; Zhan CG
    Proc Natl Acad Sci U S A; 2005 Nov; 102(46):16656-61. PubMed ID: 16275916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catalytic activities of a cocaine hydrolase engineered from human butyrylcholinesterase against (+)- and (-)-cocaine.
    Xue L; Hou S; Yang W; Fang L; Zheng F; Zhan CG
    Chem Biol Interact; 2013 Mar; 203(1):57-62. PubMed ID: 22917637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Butyrylcholinesterase Mutants for (-)-Cocaine Hydrolysis: A Correlation Relationship between Catalytic Efficiency and Total Hydrogen Bonding Energy with an Oxyanion Hole.
    Zheng F; Hou S; Xue L; Yang W; Zhan CG
    J Phys Chem B; 2023 Dec; 127(50):10723-10729. PubMed ID: 38063500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling evolution of hydrogen bonding and stabilization of transition states in the process of cocaine hydrolysis catalyzed by human butyrylcholinesterase.
    Gao D; Zhan CG
    Proteins; 2006 Jan; 62(1):99-110. PubMed ID: 16288482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Free energy perturbation simulation on transition states and high-activity mutants of human butyrylcholinesterase for (-)-cocaine hydrolysis.
    Yang W; Pan Y; Fang L; Gao D; Zheng F; Zhan CG
    J Phys Chem B; 2010 Aug; 114(33):10889-96. PubMed ID: 20677742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a high-activity mutant of human butyrylcholinesterase against (-)-cocaine.
    Yang W; Xue L; Fang L; Chen X; Zhan CG
    Chem Biol Interact; 2010 Sep; 187(1-3):148-52. PubMed ID: 20060817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substrate selectivity of high-activity mutants of human butyrylcholinesterase.
    Hou S; Xue L; Yang W; Fang L; Zheng F; Zhan CG
    Org Biomol Chem; 2013 Nov; 11(43):7477-85. PubMed ID: 24077614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic characterization of a cocaine hydrolase engineered from mouse butyrylcholinesterase.
    Chen X; Huang X; Geng L; Xue L; Hou S; Zheng X; Brimijoin S; Zheng F; Zhan CG
    Biochem J; 2015 Mar; 466(2):243-51. PubMed ID: 25486543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational design of an enzyme mutant for anti-cocaine therapeutics.
    Zheng F; Zhan CG
    J Comput Aided Mol Des; 2008 Sep; 22(9):661-71. PubMed ID: 17989928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Free-energy perturbation simulation on transition states and redesign of butyrylcholinesterase.
    Yang W; Pan Y; Zheng F; Cho H; Tai HH; Zhan CG
    Biophys J; 2009 Mar; 96(5):1931-8. PubMed ID: 19254552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling effects of oxyanion hole on the ester hydrolysis catalyzed by human cholinesterases.
    Gao D; Zhan CG
    J Phys Chem B; 2005 Dec; 109(48):23070-6. PubMed ID: 16854005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, preparation, and characterization of high-activity mutants of human butyrylcholinesterase specific for detoxification of cocaine.
    Xue L; Ko MC; Tong M; Yang W; Hou S; Fang L; Liu J; Zheng F; Woods JH; Tai HH; Zhan CG
    Mol Pharmacol; 2011 Feb; 79(2):290-7. PubMed ID: 20971807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fundamental reaction mechanism for cocaine hydrolysis in human butyrylcholinesterase.
    Zhan CG; Zheng F; Landry DW
    J Am Chem Soc; 2003 Mar; 125(9):2462-74. PubMed ID: 12603134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular dynamics simulation of cocaine binding with human butyrylcholinesterase and its mutants.
    Hamza A; Cho H; Tai HH; Zhan CG
    J Phys Chem B; 2005 Mar; 109(10):4776-82. PubMed ID: 16851561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amino-acid mutations to extend the biological half-life of a therapeutically valuable mutant of human butyrylcholinesterase.
    Fang L; Hou S; Xue L; Zheng F; Zhan CG
    Chem Biol Interact; 2014 May; 214():18-25. PubMed ID: 24582612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catalytic activities of cocaine hydrolases against the most toxic cocaine metabolite norcocaethylene.
    Zheng X; Chen X; Zhang T; Zhan M; Zhan CG; Zheng F
    Org Biomol Chem; 2020 Mar; 18(10):1968-1977. PubMed ID: 32101217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic characterization of high-activity mutants of human butyrylcholinesterase for the cocaine metabolite norcocaine.
    Zhan M; Hou S; Zhan CG; Zheng F
    Biochem J; 2014 Jan; 457(1):197-206. PubMed ID: 24125115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicted Michaelis-Menten complexes of cocaine-butyrylcholinesterase. Engineering effective butyrylcholinesterase mutants for cocaine detoxication.
    Sun H; El Yazal J; Lockridge O; Schopfer LM; Brimijoin S; Pang YP
    J Biol Chem; 2001 Mar; 276(12):9330-6. PubMed ID: 11104759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Indian butyrylcholinesterase variant L307P is not structurally stable: a molecular dynamics simulation study.
    David SM; Venkatesan SK; Boopathy R
    Chem Biol Interact; 2013 Mar; 203(1):30-5. PubMed ID: 23123771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.